USA and Canada only:
The Alliance for Cancer Gene Therapy, the only public charity in the United States dedicated exclusively to funding cancer gene therapy research, is accepting abstract submissions for its Fund for Discovery Young Investigators awards.
The Fund for Discovery will provide grants of up to $500,000 over three years to young investigators (tenure track assistant professors) conducting innovative exploratory research.
The overall objectives of this grant are to advance gene therapy into the causes, treatment, and prevention of all types of cancer by promoting development of novel and innovative studies by young investigators. The emphasis of this initiative is to promote basic and pre-clinical research approaches utilizing cells and genes as medicine. ACGT will direct its grants into areas of gene therapy research that have demonstrated great promise. The six main areas of research ACGT will support include tumor-specific replicating viruses and bacteria, anti-angiogenesis, immune-mediated gene therapy and cancer vaccines, oncogenes/suppressor oncogenes/apoptosis directed therapy, tumor targeting and vector development, and other cancer gene therapy research.
At the time of award activation, candidates must hold an M.D., M.P.H., Ph.D., or equivalent degree and be a tenure-track assistant professor within five years of their initial appointment to this rank. The investigator must be conducting original research as an independent faculty member. ACGT has no citizenship restrictions; however, research supported by the award must be conducted at medical schools and research centers only in the United States and Canada.